Speakers

listenorphandrugs

Call for speakers
If you would like to participate as a keynote presenter, panelist, or roundtable moderator, please contact the Content Director with your contact details and topic of interest at:

Fruzsina Steiner, Content Director
Phone: +46 8 6760270
E-mail:fruzsina.steiner (at) midfieldmedia.com

Agenda

Orphan-Drugs-2013-Agenda-1

Download the Orphan Drugs Summit 2013 agenda as a PDF- file:

Download your agenda here >>

Testimonials

Useful content, many new ideas and topics to follow-up 
- Global Project Leader, GHEOR Global Market Access, Bayer HealthCare

A great event, created by the hight quality of the speakers, the right amount of interactivity and the heterogeneity of the participants!
Buisness Development Manager Europe, Hospira One 2 One

Great coverage of Orphan Drug issues and opportunities
- CEO, TikoMed

Community

Mark my calendar for Pricing Conference

Become a partner for Pricing Conference

Register Now for Pricing Conference

Join our community for Pricing Conference

Welcome to Orphan Drugs Summit 2013

In 2013 Copenhagen is hosting Orphan Drugs Summit for the third time and it offers you again the unique opportunity to meet and interact with all major stakeholders. Orphan Drugs Summit is not only the leading rare disease event in Northern Europe but also a well-established platform where small and big pharmaceutical companies, hospital representatives, researchers, patient organizations, venture capitalists, regulatory bodies, industry associations discuss and influence the future of orphan drugs. The Summit is designed to increase interaction among participants, promote knowledge flow and instigate partnerships and alliances for those working with orphan drugs.

Building on the feedback of our past delegates, we have further increased networking opportunities and invited leading industry professionals with gripping presentations to address the following topics:
  • Market Access challenges and strategies
  • Incentives & regulatory framework
  • Patient registries
  • Access to Orphan Drugs
  • Partnerships and Financing
  • Pricing & Reimbursement
  • Scientific & Clinical Development
Welcome on board and I hope you will enjoy the 3rd Orphan Drugs Summit in Copenhagen on 11-13 September 2013.

Fruzsina Steiner, Content Director, Orphan Drugs Summit 2013

RSS Orphan Drugs News

Orphan Drugs Summit Partners 2013

mytomorrows
Pharmagenesis
QCTR
PSR

Networking

Meet the Market In a speed dating style, this ice-breaker networking opportunity will enable you to better know the speakers, delegates and business partners with whom you’ll be spending the next days. Get ready to meet the market!

Orphan Drugs Café Our ice-breaker morning session welcomes speakers, business partners and delegates to discuss the main challenges and cutting edge topics of the conference in a relaxed atmosphere. Let´s break the ice and get the show on the road!

Quick Fire Presentations In each of our main conference blocks, leading industry professional will address different aspects of the same theme in 20-minute presentations.

Panel discussions Our interactive panels address the most relevant challenges of the Orphan Drugs universe. Panellists share their own thoughts and react to the audience’s questions.

Executive Circles Several round tables are set each with a specific subtopic. You as a delegate have a chance to discuss the most relevant challenges with your peers in a relaxed atmosphere. You can join maximum 2 tables, each for 30 minutes.

Fishbowl TThe speaker of the Fishbowl is going to be a keynote presenter of the highest degree: he encompasses vast experience in business intelligence with incomparable knowledge of many different industries. He knows the current and emerging trends in the business due to his many years spent in the field. The speaker of the Fishbowl is … you!

Exclusive Networking Dinner If you go to conferences to network, this is your time to shine. Top notch dinner with premium networking time among industry peers.

Meet your peers at Orphan Drugs Summit 2013!

Main stakeholder groups attending:
  • Pharmaceutical companies
  • Biotech organisations
  • Patient organisations
  • Patient Access Insitutions
  • Global / European / National Regulatory Bodies
  • HTAs
  • Academia / Research Centres
  • Hospitals
Typical delegate titles:
  • CEO
  • CFO
  • CTO
  • CMO
  • VP / Head / Director of Business Development
  • VP / Head / Director of Clinical Trial
  • VP / Head / Director of Therepeutics
  • VP / Head / Director of Market Access
  • VP / Head / Director of Regulatory
  • VP / Head / Director of Public Policy